The recent meetings of the CDC vaccine advisory panel have been marked by significant upheaval and controversy. Day 2 of the discussions opened with unexpected reversals regarding vaccine recommendations, including delays on the hepatitis B vaccine vote and new restrictions on the MMRV vaccine options for younger children. RFK Jr.’s handpicked advisers, who have been criticized for their anti-vaccine stance, are pushing for dramatic changes to childhood vaccination schedules, raising concerns among health experts. Key discussions included the future of COVID-19 vaccines and the controversial decision to postpone a vote on newborn hepatitis B shots. As the advisory panel continues to grapple with these issues, experts warn of potential decreases in vaccine access and public health risks associated with these new directions.